MapLight Therapeutics, Inc. Common Stock Financial Flexibility Index
MapLight Therapeutics, Inc. Common Stock financial flexibility index. MapLight Therapeutics, Inc. Common Stock (MPLT) has a Financial Flexibility Index of -2.24x as of June 2026. Free cash flow of $-44.85 Million (operating CF $-44.87 Million minus capex $22.00K) represents -2% of total liabilities ($20.05 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of MapLight Therapeutics, Inc. Common Stock (2022–2025)
Financial flexibility index of MapLight Therapeutics, Inc. Common Stock from 2022 to 2025. Historical Financial Flexibility Index trend for MapLight Therapeutics, Inc. Common Stock across 4 annual periods. Explore MapLight Therapeutics, Inc. Common Stock (MPLT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
MapLight Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2022–2025)
MapLight Therapeutics, Inc. Common Stock financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for MapLight Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see MPLT cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.51x | $-137.66 Million | $-138.14 Million | $21.14 Million | ▼ -81.2% |
| 2024 | -3.59x | $-78.05 Million | $-78.81 Million | $21.72 Million | ▼ -40.3% |
| 2023 | -2.56x | $-51.54 Million | $-52.01 Million | $20.13 Million | ▼ -83.6% |
| 2022 | -1.39x | $-25.83 Million | $-26.58 Million | $18.52 Million | — |